A $3.2-million grant from the National Institutes of Health has been awarded to the collaborative work between Northeastern University’s Spring Lab and Cellaria into a new method of eliminating the microscopic cancerous tumors left behind by standard therapies. The approach uses antibody-photosensitizer molecules that make cancer cells susceptible to light-induced destruction. Researchers will mainly focus on ovarian and pancreatic cancer — whose residual microscopic tumors can spread into the abdomen, attacking other organs. Microscopic clusters…
You must be logged in to read/download the full post.
The post $3.2M NIH Grant Supports Development of New Approach to Target ‘Invisible’ Residual Tumors appeared first on BioNewsFeeds.